Nanoscale:上海交大六院汪泱教授利用水凝胶缓释干细胞外泌体促进关节软骨的再生

2017-03-15 外泌体之家 外泌体之家

关节软骨几乎没有先天自愈的再生能力是临床治疗中的巨大挑战。干细胞衍生的外泌体(SC-Exos)是一种重要类型的细胞外纳米泡,对于代替基于干细胞的治疗的软骨再生显示出巨大的潜力。目前还没有有效的给药方法能够在软骨缺损部位持久保留外泌体,有效发挥其修复作用;然而软骨再生通常需要相对长的时间。因此,在这项研究中,来自上海交通大学附属第六人民医院的汪泱研究员和华东理工大学的研究人员合作开发了光诱导亚胺交联

关节软骨几乎没有先天自愈的再生能力是临床治疗中的巨大挑战。干细胞衍生的外泌体(SC-Exos)是一种重要类型的细胞外纳米泡,对于代替基于干细胞的治疗的软骨再生显示出巨大的潜力。目前还没有有效的给药方法能够在软骨缺损部位持久保留外泌体,有效发挥其修复作用;然而软骨再生通常需要相对长的时间。因此,在这项研究中,来自上海交通大学附属第六人民医院的汪泱研究员和华东理工大学的研究人员合作开发了光诱导亚胺交联水凝胶胶,呈现出优良的操作能力、生物相容性和最重要的软骨整合能力,可作为外泌体支架用作软骨再生的无细胞组织补丁(EHG)。研究发现EHG可以将SC-Exos保留在内部并在体外正调节软骨细胞和hBMSCs。此外,EHG可以与自身软骨基质整合,并促进细胞沉积在软骨缺损部位,最终促进软骨缺损修复。希望EHG组织补丁将提供一种新的无细胞支架材料用于帮助伤口修复。

参考文献:

Liu X, Yang Y, Li Y, et al. Integration of Stem Cell-Derived Exosomes with In Situ Hydrogel Glue as a Promising Tissue Patch for Articular Cartilage Regeneration[J]. Nanoscale, 2017.  IF=7.76

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1793650, encodeId=6b3d1e936503e, content=<a href='/topic/show?id=e40315955e3' target=_blank style='color:#2F92EE;'>#scale#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15955, encryptionId=e40315955e3, topicName=scale)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68b666, createdName=zhangying8788, createdTime=Fri May 26 09:20:00 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735904, encodeId=b8ba1e3590418, content=<a href='/topic/show?id=2af23014609' target=_blank style='color:#2F92EE;'>#关节软骨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30146, encryptionId=2af23014609, topicName=关节软骨)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165434038855, createdName=anan, createdTime=Wed Feb 28 23:20:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307994, encodeId=54c2130e99462, content=<a href='/topic/show?id=edd364149bc' target=_blank style='color:#2F92EE;'>#水凝胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64149, encryptionId=edd364149bc, topicName=水凝胶)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Fri Mar 17 07:20:00 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460924, encodeId=f29614609240a, content=<a href='/topic/show?id=de4331310a4' target=_blank style='color:#2F92EE;'>#凝胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31310, encryptionId=de4331310a4, topicName=凝胶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e09e6383467, createdName=lishizhe, createdTime=Fri Mar 17 07:20:00 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553819, encodeId=a7af1553819b1, content=<a href='/topic/show?id=0ba81988692' target=_blank style='color:#2F92EE;'>#上海交大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19886, encryptionId=0ba81988692, topicName=上海交大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a6414444709, createdName=gao_jian4222, createdTime=Fri Mar 17 07:20:00 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180119, encodeId=88b918011965, content=研究创新性很强, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Mar 15 16:48:33 CST 2017, time=2017-03-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1793650, encodeId=6b3d1e936503e, content=<a href='/topic/show?id=e40315955e3' target=_blank style='color:#2F92EE;'>#scale#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15955, encryptionId=e40315955e3, topicName=scale)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68b666, createdName=zhangying8788, createdTime=Fri May 26 09:20:00 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735904, encodeId=b8ba1e3590418, content=<a href='/topic/show?id=2af23014609' target=_blank style='color:#2F92EE;'>#关节软骨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30146, encryptionId=2af23014609, topicName=关节软骨)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165434038855, createdName=anan, createdTime=Wed Feb 28 23:20:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307994, encodeId=54c2130e99462, content=<a href='/topic/show?id=edd364149bc' target=_blank style='color:#2F92EE;'>#水凝胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64149, encryptionId=edd364149bc, topicName=水凝胶)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Fri Mar 17 07:20:00 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460924, encodeId=f29614609240a, content=<a href='/topic/show?id=de4331310a4' target=_blank style='color:#2F92EE;'>#凝胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31310, encryptionId=de4331310a4, topicName=凝胶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e09e6383467, createdName=lishizhe, createdTime=Fri Mar 17 07:20:00 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553819, encodeId=a7af1553819b1, content=<a href='/topic/show?id=0ba81988692' target=_blank style='color:#2F92EE;'>#上海交大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19886, encryptionId=0ba81988692, topicName=上海交大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a6414444709, createdName=gao_jian4222, createdTime=Fri Mar 17 07:20:00 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180119, encodeId=88b918011965, content=研究创新性很强, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Mar 15 16:48:33 CST 2017, time=2017-03-15, status=1, ipAttribution=)]
    2018-02-28 anan
  3. [GetPortalCommentsPageByObjectIdResponse(id=1793650, encodeId=6b3d1e936503e, content=<a href='/topic/show?id=e40315955e3' target=_blank style='color:#2F92EE;'>#scale#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15955, encryptionId=e40315955e3, topicName=scale)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68b666, createdName=zhangying8788, createdTime=Fri May 26 09:20:00 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735904, encodeId=b8ba1e3590418, content=<a href='/topic/show?id=2af23014609' target=_blank style='color:#2F92EE;'>#关节软骨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30146, encryptionId=2af23014609, topicName=关节软骨)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165434038855, createdName=anan, createdTime=Wed Feb 28 23:20:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307994, encodeId=54c2130e99462, content=<a href='/topic/show?id=edd364149bc' target=_blank style='color:#2F92EE;'>#水凝胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64149, encryptionId=edd364149bc, topicName=水凝胶)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Fri Mar 17 07:20:00 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460924, encodeId=f29614609240a, content=<a href='/topic/show?id=de4331310a4' target=_blank style='color:#2F92EE;'>#凝胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31310, encryptionId=de4331310a4, topicName=凝胶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e09e6383467, createdName=lishizhe, createdTime=Fri Mar 17 07:20:00 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553819, encodeId=a7af1553819b1, content=<a href='/topic/show?id=0ba81988692' target=_blank style='color:#2F92EE;'>#上海交大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19886, encryptionId=0ba81988692, topicName=上海交大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a6414444709, createdName=gao_jian4222, createdTime=Fri Mar 17 07:20:00 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180119, encodeId=88b918011965, content=研究创新性很强, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Mar 15 16:48:33 CST 2017, time=2017-03-15, status=1, ipAttribution=)]
    2017-03-17 tastas
  4. [GetPortalCommentsPageByObjectIdResponse(id=1793650, encodeId=6b3d1e936503e, content=<a href='/topic/show?id=e40315955e3' target=_blank style='color:#2F92EE;'>#scale#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15955, encryptionId=e40315955e3, topicName=scale)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68b666, createdName=zhangying8788, createdTime=Fri May 26 09:20:00 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735904, encodeId=b8ba1e3590418, content=<a href='/topic/show?id=2af23014609' target=_blank style='color:#2F92EE;'>#关节软骨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30146, encryptionId=2af23014609, topicName=关节软骨)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165434038855, createdName=anan, createdTime=Wed Feb 28 23:20:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307994, encodeId=54c2130e99462, content=<a href='/topic/show?id=edd364149bc' target=_blank style='color:#2F92EE;'>#水凝胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64149, encryptionId=edd364149bc, topicName=水凝胶)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Fri Mar 17 07:20:00 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460924, encodeId=f29614609240a, content=<a href='/topic/show?id=de4331310a4' target=_blank style='color:#2F92EE;'>#凝胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31310, encryptionId=de4331310a4, topicName=凝胶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e09e6383467, createdName=lishizhe, createdTime=Fri Mar 17 07:20:00 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553819, encodeId=a7af1553819b1, content=<a href='/topic/show?id=0ba81988692' target=_blank style='color:#2F92EE;'>#上海交大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19886, encryptionId=0ba81988692, topicName=上海交大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a6414444709, createdName=gao_jian4222, createdTime=Fri Mar 17 07:20:00 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180119, encodeId=88b918011965, content=研究创新性很强, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Mar 15 16:48:33 CST 2017, time=2017-03-15, status=1, ipAttribution=)]
    2017-03-17 lishizhe
  5. [GetPortalCommentsPageByObjectIdResponse(id=1793650, encodeId=6b3d1e936503e, content=<a href='/topic/show?id=e40315955e3' target=_blank style='color:#2F92EE;'>#scale#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15955, encryptionId=e40315955e3, topicName=scale)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68b666, createdName=zhangying8788, createdTime=Fri May 26 09:20:00 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735904, encodeId=b8ba1e3590418, content=<a href='/topic/show?id=2af23014609' target=_blank style='color:#2F92EE;'>#关节软骨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30146, encryptionId=2af23014609, topicName=关节软骨)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165434038855, createdName=anan, createdTime=Wed Feb 28 23:20:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307994, encodeId=54c2130e99462, content=<a href='/topic/show?id=edd364149bc' target=_blank style='color:#2F92EE;'>#水凝胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64149, encryptionId=edd364149bc, topicName=水凝胶)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Fri Mar 17 07:20:00 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460924, encodeId=f29614609240a, content=<a href='/topic/show?id=de4331310a4' target=_blank style='color:#2F92EE;'>#凝胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31310, encryptionId=de4331310a4, topicName=凝胶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e09e6383467, createdName=lishizhe, createdTime=Fri Mar 17 07:20:00 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553819, encodeId=a7af1553819b1, content=<a href='/topic/show?id=0ba81988692' target=_blank style='color:#2F92EE;'>#上海交大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19886, encryptionId=0ba81988692, topicName=上海交大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a6414444709, createdName=gao_jian4222, createdTime=Fri Mar 17 07:20:00 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180119, encodeId=88b918011965, content=研究创新性很强, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Mar 15 16:48:33 CST 2017, time=2017-03-15, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1793650, encodeId=6b3d1e936503e, content=<a href='/topic/show?id=e40315955e3' target=_blank style='color:#2F92EE;'>#scale#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15955, encryptionId=e40315955e3, topicName=scale)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68b666, createdName=zhangying8788, createdTime=Fri May 26 09:20:00 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735904, encodeId=b8ba1e3590418, content=<a href='/topic/show?id=2af23014609' target=_blank style='color:#2F92EE;'>#关节软骨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30146, encryptionId=2af23014609, topicName=关节软骨)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165434038855, createdName=anan, createdTime=Wed Feb 28 23:20:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307994, encodeId=54c2130e99462, content=<a href='/topic/show?id=edd364149bc' target=_blank style='color:#2F92EE;'>#水凝胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64149, encryptionId=edd364149bc, topicName=水凝胶)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Fri Mar 17 07:20:00 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460924, encodeId=f29614609240a, content=<a href='/topic/show?id=de4331310a4' target=_blank style='color:#2F92EE;'>#凝胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31310, encryptionId=de4331310a4, topicName=凝胶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e09e6383467, createdName=lishizhe, createdTime=Fri Mar 17 07:20:00 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553819, encodeId=a7af1553819b1, content=<a href='/topic/show?id=0ba81988692' target=_blank style='color:#2F92EE;'>#上海交大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19886, encryptionId=0ba81988692, topicName=上海交大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a6414444709, createdName=gao_jian4222, createdTime=Fri Mar 17 07:20:00 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180119, encodeId=88b918011965, content=研究创新性很强, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Mar 15 16:48:33 CST 2017, time=2017-03-15, status=1, ipAttribution=)]
    2017-03-15 doctorJiangchao

    研究创新性很强

    0

相关资讯

Stem Cells:多能成年祖细胞通过调节脾中免疫反应提高中风后的恢复

干细胞治疗不仅能够调节大脑的局部微环境,而且可以调节全身免疫应答。近期,一项发表在杂志Stem cells上的研究探讨了调节缺血性卒中后脾脏激活和外周免疫应答的人多能成年祖细胞(MAPC)的影响。此项研究共使用一百二十六只Long-Evans成年雄性大鼠,建立大脑中动脉闭塞。 24小时后,它们接受静脉输注MAPC或盐水治疗。在输注后3天,从损伤的皮质和脾脏中分离RNA用于微阵列分析。测量脾脏质量,

干细胞疗法或有望根治心脏病

据美国CDC数据显示,在美国每隔43秒就会有人心脏病发作;如今,人群中心肌梗死和心力衰竭的高发病率和临床疗效的有限性催生着人们对干细胞疗法的厚望,目前全球已有数千名患者接受了成体干细胞的治疗。日前,来自日本的科学家使用一只猕猴干细胞培育出的心肌细胞成功修复了其它五只猴子的破损心脏,这一研究突破就表明未来科学家或许能够借助捐赠的干细胞让心脏病患者的器官得以再生,而且这种方法还能够

Kidney Int:间充质干细胞衍生的胞外囊泡可以减弱肾脏炎症

间充质干细胞(MSC)具有不同的肾脏修复能力,但可能存在安全问题。 MSC衍生的胞外囊泡成为一种新的非细胞性替代物。近期,一项发表在杂志Kidney Int上的研究使用了代谢综合征和肾动脉狭窄的猪模型,测试了细胞外囊泡是否能够减弱肾脏炎症,并且这种能力是都由其抗炎细胞因子白细胞介素(IL)10的载体介导。研究者们首先从脂肪组织来源的自体MSC收获了细胞外囊泡,建立猪的肾动脉狭窄模型,16

2017国际干细胞心肌修复转化医学论坛

本次论坛聚焦心血管细胞命运决定、非编码RNA与干细胞心肌修复、干细胞与心脏疾病模型和药物筛选、心血管细胞重编程、转分化与再生、干细胞及衍生物与心肌修复、心血管组织和器官构建、心肌干细胞产品质量控制等热点,旨在交流最新的研究进展,共同探索干细胞心肌修复的基础、转化医学和再生医学的发展前沿,促进交流合作。

汇总:近期干细胞相关研究进展

干细胞(stem cells,SC)被称为“万能细胞”,是一类具有自我复制能力(self-renewing)的多潜能细胞,干细胞是一种未充分分化,尚不成熟的细胞,具有再生各种组织器官和人体的潜在功能。跟APSC多能细胞一样,是一类具有自我复制和多向分化潜能的原始细胞,它也是维持生命不息的最基本动力,多功能活化细胞抗衰老就是通过利用由自体采集的组织细胞,经实验室分离、培养后,将增殖的干细胞注入回

Cell Stem Cell:靶向癌症干细胞提高了癌症治疗效果并可防止转移

根据 UCLA 癌症研究人员的一项新研究,靶向癌症干细胞可能是克服癌症耐药性和预防鳞状细胞癌(最常见的头颈部癌和第二最常见的皮肤癌)的更有效的方法。